Clinical trial · Interventional
Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy
Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy: π-shape Esophagojejunostomy, Three-in-one Technique
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Laparoscopic gastrectomy became a good option for early gastric cancer. Surgical trend is gradually changed to totally laparoscopic gastrectomy from laparoscopy-assisted gastrectomy requiring mini-laparotomy. Various types of intracorporeal anastomosis have been introduced for esophagojejunostomy during total gastrectomy. We invented a novel anastomosis method using linear stapler for total gastrectomy. Three procedures (Jejunal resection, esophageal resection and closure of common entry hole after anastomosis) was performed with only one stapler. Therefore, the novel method is simple and fast. Also, this new technique is better economically than previously introduced anastomosis using linear stapler because lesser number of stapler is required. We want to demonstrate the feasibility of novel intracorporeal anastomosis method during laparoscopic total gastrectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intracorporeal esophagojejunostomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intracorporeal esophagojejunostomy
- description
- Patient group with intracorporeal esophagojejunostomy with linear stapler
- interventionNames
- Procedure: Intracorporeal esophagojejunostomy
Primary outcomes (1)
- measure
- Anastomosis related complication rate
- timeFrame
- During 30 days after operation
- description
- Anastomotic leakage, intraluminal bleeding, or stenosis were considered as anastomosis related complication
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed adenocarcinoma in stomach * Males or Females, aged≥20 years and ≤80 years * Without serosa invasion, extraperigastric lymph node metastasis and other organ metastasis stage in preoperative evaluation, (cT1-3N0-1M0) * Beyond the indication of ESD * Tumor location in high body of stomach or requiring total gastrectomy * Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 or 1 at study entry * American Society of Anesthesiolosists (ASA) score of 1 to 3 * The patient has given their written informed consent to participate in the study Exclusion Criteria: * Simultaneous malignancy in other organ * Experience of previous laparotomy * Experience of gastric resection including wedge resection * Vulnerable subject
References
Publications (0)
Data not yet available